Stimulating arteriogenesis but not atherosclerosis: IFN-α/β receptor subunit 1 as a novel therapeutic target

Cardiovasc Res. 2015 Jul 15;107(2):200-2. doi: 10.1093/cvr/cvv174. Epub 2015 Jun 17.

Authors

Clément Cochain¹, Alma Zernecke²

Affiliations

¹ Institute of Clinical Biochemistry and Pathobiochemistry, University Hospital Würzburg, Josef-Schneider-Str. 2, Würzburg 97080, Germany.
² Institute of Clinical Biochemistry and Pathobiochemistry, University Hospital Würzburg, Josef-Schneider-Str. 2, Würzburg 97080, Germany alma.zernecke@uni-wuerzburg.de.

PMID: 26084309
DOI: 10.1093/cvr/cvv174

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Antibodies, Monoclonal / therapeutic use*
Atherosclerosis / drug therapy*
Femoral Artery / immunology*
Hindlimb / drug effects*
Hindlimb / immunology*
Ischemia / drug therapy*
Receptor, Interferon alpha-beta / immunology*

Substances

Antibodies, Monoclonal
Receptor, Interferon alpha-beta